To cite this paper use one of the standards below:
Cubosomes stand for dispersions of lyotropic liquid crystalline nanostructures bearing a bicontinuous cubic reverse arrangement that combine the ability to entrap both hydrophilic and hydrophobic molecules. Cubosomes were produced as detailed elsewhere1 using phytantriol and Pluronic® F-127. This host (cubosome)/guest (drug) approach was validated here with sodium diclofenac as a model drug, while the cubosomes themselves served as guests hosted by a hydrated network of bacterial cellulose (BC), wherein the nanostructures were entrapped by in situ and ex situ strategies. The BC membrane was produced in Hestrin-Schramm (HS) medium by Komagataeibacter xylinus cells. We propose an in situ immobilization protocol, by producing bacterial cellulose (BC) in cubosome-containing HS medium, as well as an ex situ protocol, via freeze-drying of the BC membranes followed by their reswelling in a cubosome dispersion. SAXS and high-resolution confocal microscopy confirmed the persistence of the internal cubic bicontinuous structure and that the cubosomes were evenly spread over the BC membranes in both methods. We hypothesize two mechanisms for sodium diclofenac delivery from BC membranes, namely: (i) sustained release of the cubosome-entrapped diclofenac and (ii) cubosome leaching from the BC membranes. Altogether, we put forward the use of cubosome-loaded BC membranes for biomedical applications, mainly skin therapies involving drug delivery.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper